ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) Operating cash flow 2015–2024
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$73.2MFY2024 · since FY2015: -$29.7M → -$73.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$73.2M | +48.0% |
| FY2023 | -$140.9M | +0.6% |
| FY2022 | -$141.8M | -1421.4% |
| FY2021 | $10.7M | +120.0% |
| FY2020 | -$53.6M | +52.4% |
| FY2019 | -$112.5M | -7.8% |
| FY2018 | -$104.4M | -92.2% |
| FY2017 | -$54.3M | -12.8% |
| FY2016 | -$48.2M | -62.4% |
| FY2015 | -$29.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice